Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
Where
Beijing
People
285
Run by
Shu Wang
See details and how to joinNCT06711055
No phaseTaking people
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
Where
Beijing
People
8,077
Run by
Shu Wang
See details and how to joinNCT06711068
Phase 4Enrolling by invitation
Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
Where
Wuhan
Age
1 day to 7 years
People
180
Run by
Yilin Zhao
See details and how to joinNCT06711679
No phaseNot yet taking people in China
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
Where
Shanghai
People
100
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06608225
No phaseTaking people
De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
Where
Beijing
People
519
Run by
Shu Wang
See details and how to joinNCT06700369
No phaseTaking people
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC
Where
Beijing
People
1,166
Run by
Shu Wang
See details and how to joinNCT06700382
Phase 2Taking people
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
Where
Shanghai
Age
14 years to 40 years
People
22
Run by
Fudan University
See details and how to joinNCT06699472
No phaseTaking people
De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
Where
Beijing
People
380
Run by
Peking University People's Hospital
See details and how to joinNCT06692725
No phaseTaking people
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
Where
Beijing
People
2,806
Run by
Shu Wang
See details and how to joinNCT06693024
No phaseTaking people
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy
Where
Beijing
People
2,092
Run by
Shu Wang
See details and how to joinNCT06693037
Early phase 1Taking people
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Where
Suzhou
Age
14 years and over
People
18
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06696833
No phaseEnrolling by invitation
Perioperative Treatment Outcomes of Early NSCLC
Where
Shanghai
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT06610240
Phase 1/2Taking people
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
Where
Beijing
Age
6 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06420063
Phase 1/2Taking people
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
Where
Beijing
Age
2 years to 90 years
People
60
Run by
Essen Biotech
See details and how to joinNCT06420076
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Where
Beijing
Age
16 years to 90 years
People
75
Run by
Essen Biotech
See details and how to joinNCT06532799
Phase 1/2Taking people
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06532812
Phase 1/2Taking people
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06530303
Phase 2Taking people
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
Where
Tianjin
Age
16 years to 70 years
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06608732
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06640582
Phase 3Not yet taking people in China
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
Where
Suzhou
Age
2 years to 55 years
People
430
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06673459
Phase 1Not yet taking people in China
CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
Where
Zhengzhou
Age
14 years to 75 years
People
30
Run by
Mingzhi Zhang
See details and how to joinNCT06647329
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06538012
Early phase 1Taking people
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
Where
Hangzhou
People
30
Run by
Zhejiang University
See details and how to joinNCT06633341
Early phase 1Taking people
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
Where
Hangzhou
People
30
Run by
Zhejiang University
See details and how to joinNCT06633354
Phase 2/3Taking people
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
Where
Fuzhou, Hefei, Ningbo, Shanghai
Age
1 month to 18 years
People
90
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06607419